PMID- 31127058 OWN - NLM STAT- MEDLINE DCOM- 20200211 LR - 20211204 IS - 1939-327X (Electronic) IS - 0012-1797 (Linking) VI - 68 IP - 8 DP - 2019 Aug TI - Polarity Protein AF6 Controls Hepatic Glucose Homeostasis and Insulin Sensitivity by Modulating IRS1/AKT Insulin Pathway in an SHP2-Dependent Manner. PG - 1577-1590 LID - 10.2337/db18-0695 [doi] AB - Insulin resistance is a major contributing factor in the development of metabolic disease. Although numerous functions of the polarity protein AF6 (afadin and MLLT4) have been identified, a direct effect on insulin sensitivity has not been previously described. We show that AF6 is elevated in the liver tissues of dietary and genetic mouse models of diabetes. We generated liver-specific AF6 knockout mice and show that these animals exhibit enhanced insulin sensitivity and liver glycogen storage, whereas overexpression of AF6 in wild-type mice by adenovirus-expressing AF6 led to the opposite phenotype. Similar observations were obtained from in vitro studies. In addition, we discovered that AF6 directly regulates IRS1/AKT kinase-mediated insulin signaling through its interaction with Src homology 2 domain-containing phosphatase 2 (SHP2) and its regulation of SHP2's tyrosine phosphatase activity. Finally, we show that knockdown of hepatic AF6 ameliorates hyperglycemia and insulin resistance in high-fat diet-fed or db/db diabetic mice. These results demonstrate a novel function for hepatic AF6 in the regulation of insulin sensitivity, providing important insights about the metabolic role of AF6. CI - (c) 2019 by the American Diabetes Association. FAU - Dai, Cheng AU - Dai C AD - CAS Key Laboratory of Nutrition, Metabolism and Food Safety, Shanghai Institute of Nutrition and Health, Shanghai Institutes for Biological Sciences, University of Chinese Academy of Sciences, Chinese Academy of Sciences, Shanghai, China. FAU - Wang, Xinyu AU - Wang X AD - CAS Key Laboratory of Nutrition, Metabolism and Food Safety, Shanghai Institute of Nutrition and Health, Shanghai Institutes for Biological Sciences, University of Chinese Academy of Sciences, Chinese Academy of Sciences, Shanghai, China. FAU - Wu, Yanjun AU - Wu Y AD - CAS Key Laboratory of Nutrition, Metabolism and Food Safety, Shanghai Institute of Nutrition and Health, Shanghai Institutes for Biological Sciences, University of Chinese Academy of Sciences, Chinese Academy of Sciences, Shanghai, China. FAU - Xu, Yi AU - Xu Y AD - CAS Key Laboratory of Nutrition, Metabolism and Food Safety, Shanghai Institute of Nutrition and Health, Shanghai Institutes for Biological Sciences, University of Chinese Academy of Sciences, Chinese Academy of Sciences, Shanghai, China. FAU - Zhuo, Shu AU - Zhuo S AD - CAS Key Laboratory of Nutrition, Metabolism and Food Safety, Shanghai Institute of Nutrition and Health, Shanghai Institutes for Biological Sciences, University of Chinese Academy of Sciences, Chinese Academy of Sciences, Shanghai, China. FAU - Qi, Meiyan AU - Qi M AD - CAS Key Laboratory of Nutrition, Metabolism and Food Safety, Shanghai Institute of Nutrition and Health, Shanghai Institutes for Biological Sciences, University of Chinese Academy of Sciences, Chinese Academy of Sciences, Shanghai, China. FAU - Ji, Weiwei AU - Ji W AD - CAS Key Laboratory of Nutrition, Metabolism and Food Safety, Shanghai Institute of Nutrition and Health, Shanghai Institutes for Biological Sciences, University of Chinese Academy of Sciences, Chinese Academy of Sciences, Shanghai, China. FAU - Zhan, Lixing AU - Zhan L AUID- ORCID: 0000-0003-4949-4358 AD - CAS Key Laboratory of Nutrition, Metabolism and Food Safety, Shanghai Institute of Nutrition and Health, Shanghai Institutes for Biological Sciences, University of Chinese Academy of Sciences, Chinese Academy of Sciences, Shanghai, China lxzhan@sibs.ac.cn. LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20190524 PL - United States TA - Diabetes JT - Diabetes JID - 0372763 RN - 0 (Afdn protein, mouse) RN - 0 (Insulin) RN - 0 (Insulin Receptor Substrate Proteins) RN - 0 (Irs1 protein, mouse) RN - EC 2.7.11.1 (Proto-Oncogene Proteins c-akt) RN - EC 3.1.3.48 (Protein Tyrosine Phosphatase, Non-Receptor Type 11) RN - EC 3.6.4.1 (Myosins) RN - EC 3.6.4.4 (Kinesins) RN - IY9XDZ35W2 (Glucose) SB - IM MH - Animals MH - Cell Line MH - Diabetes Mellitus, Experimental/*metabolism MH - Diet, High-Fat MH - Glucose/*metabolism MH - Glucose Tolerance Test MH - Hepatocytes/metabolism MH - Homeostasis/*physiology MH - Insulin/*metabolism MH - Insulin Receptor Substrate Proteins/metabolism MH - Insulin Resistance/*physiology MH - Kinesins/genetics/*metabolism MH - Liver/*metabolism MH - Male MH - Mice MH - Mice, Knockout MH - Myosins/genetics/*metabolism MH - Protein Tyrosine Phosphatase, Non-Receptor Type 11/*metabolism MH - Proto-Oncogene Proteins c-akt/metabolism MH - Signal Transduction/physiology EDAT- 2019/05/28 06:00 MHDA- 2020/02/12 06:00 CRDT- 2019/05/26 06:00 PHST- 2018/06/28 00:00 [received] PHST- 2019/05/21 00:00 [accepted] PHST- 2019/05/28 06:00 [pubmed] PHST- 2020/02/12 06:00 [medline] PHST- 2019/05/26 06:00 [entrez] AID - db18-0695 [pii] AID - 10.2337/db18-0695 [doi] PST - ppublish SO - Diabetes. 2019 Aug;68(8):1577-1590. doi: 10.2337/db18-0695. Epub 2019 May 24.